drugset / Trial / NCT03862040

Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia

NCT03862040

Phase 1 Terminated 7 enrolled Shionogi
NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of the study is to determine the degree of penetration of cefiderocol into infected lung tissue in hospitalized adults with bacterial pneumonia who are being mechanically ventilated.

Timeline

Start
2019-02-20
Primary completion
2019-10-08
Completion
2019-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefiderocol Small molecule 2 g Intravenous

Indications